International Stem Cell (ISCO) Stock Chart & Stock Price History $0.13 +0.00 (+2.25%) As of 06/16/2025 01:04 PM Eastern Add Compare Share Share Chart Stock AnalysisChartEarningsHeadlinesSEC FilingsShort InterestBuy This Stock International Stem Cell Stock Price Performance The International Stem Cell (ISCO) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 58.14%, with a year-to-date return of 56.58%. In the past month, the stock has increased 15.73%, reflecting recent market activity. As of the latest close, International Stem Cell traded at $0.13 with a market cap of $1.02 million and volume of 300 shares. Five years ago, the stock traded at $0.70, representing a 81.81% decrease over that period. At the time, it had a market cap of $5.28 million and a volume of 2,188 shares. Receive ISCO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for International Stem Cell and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+6.00%1 Month PerformanceN/A3 Month Performance+26.04%Year-To-Date Performance+56.58%1 Year PerformanceN/A5 Year Performance-81.81% ISCO Stock Chart for Tuesday, June, 17, 2025 ISCO Chart by TradingView International Stem Cell Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/16/2025$0.12$0.13+2.25%$0.13$0.13300 shs$1.02 million06/13/2025$0.12$0.12+3.66%$0.12$0.121,008 shs$996,000.0006/12/2025$0.12$0.12$0.12$0.1250 shs$961,000.0006/11/2025$0.12$0.12$0.12$0.1210,391 shs$961,000.0006/10/2025$0.13$0.12-7.62%$0.12$0.1210,391 shs$961,000.0006/06/2025$0.13$0.13$0.14$0.124,100 shs$1.04 million06/05/2025$0.14$0.13-9.72%$0.14$0.124,100 shs$1.04 million06/04/2025$0.14$0.14$0.17$0.14776 shs$1.15 million06/03/2025$0.13$0.14+9.09%$0.17$0.14776 shs$1.15 million06/02/2025$0.12$0.13+9.91%$0.13$0.13420 shs$1.06 million Get the Latest News and Ratings for ISCO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for International Stem Cell and its competitors with MarketBeat's FREE daily newsletter. 05/30/2025$0.12$0.12$0.17$0.122,250 shs$961,000.0005/29/2025$0.17$0.12-27.95%$0.17$0.122,250 shs$961,000.0005/28/2025$0.15$0.17+8.11%$0.17$0.1620,528 shs$1.33 million05/27/2025$0.11$0.15+40.18%$0.15$0.1325,064 shs$1.23 million05/26/2025$0.11$0.11$0.11$0.1135 shs$880,000.0005/23/2025$0.11$0.11$0.11$0.1112 shs$880,000.0005/22/2025$0.11$0.11$0.11$0.11240 shs$880,000.0005/21/2025$0.11$0.11$0.11$0.11240 shs$880,000.0005/20/2025$0.11$0.11$0.11$0.111,300 shs$880,000.0005/19/2025$0.11$0.11$0.11$0.1122 shs$880,000.00 Related Companies Tharimmune Stock Chart Clearmind Medicine Stock Chart PainReform Stock Chart Can-Fite BioPharma Stock Chart InMed Pharmaceuticals Stock Chart Lixte Biotechnology Stock Chart Synaptogenix Stock Chart Sonnet BioTherapeutics Stock Chart Artelo Biosciences Stock Chart Evaxion Biotech A/S Stock Chart Receive ISCO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for International Stem Cell and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:ISCO) was last updated on 6/17/2025 by MarketBeat.com Staff From Our PartnersThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWill I be blacklisted?The President’s tour of the Middle East… the deal for Ukraine’s mineral rights… Elon’s strange time in Washing...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding International Stem Cell Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share International Stem Cell With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.